A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy Cancer neoantigens and neoantigen-specific T…
Alena Gros
The Vall d’Hebron Barcelona Hospital Campus and Biocat held a new session of the ATMP Catalonia Series, titled ‘ATMPs: From…
Engineering T cells directly inside the patient’s body to turn them into CAR-T cells ready to attack tumor cells, using…
A study led by IRB Barcelona with the collaboration of different VHIO research groups describes a mechanism by which senescent…
VHIO consolidates its advanced therapy programme to develop new innovative treatments against cancer
The 1st VHIO-BBVA Foundation International Symposium on Cell-based Therapies in Oncology , organised by Dr. Alena Gros, head of the…
Non-canonical proteins are unconventional protein products that are not part of the known protein-coding genome repertoire. They arise from unexpected…
Recently published open access in the Journal for ImmunoTherapy of Cancer (1), findings from a study led by VHIO’s Alena…
